96 research outputs found

    Phenylboronic Acids Probing Molecular Recognition against Class A and Class C beta-Lactamases

    Get PDF
    Worldwide dissemination of pathogens resistant to almost all available antibiotics represent a real problem preventing efficient treatment of infectious diseases. Among antimicrobial used in therapy, \u392-lactam antibiotics represent 40% thus playing a crucial role in the management of infections treatment. We report a small series of phenylboronic acids derivatives (BAs) active against class A carbapenemases KPC-2 and GES-5, and class C cephalosporinases AmpC. The inhibitory profile of our BAs against class A and C was investigated by means of molecular docking, enzyme kinetics and X-ray crystallography. We were interested in the mechanism of recognition among class A and class C to direct the design of broad serine \u392-Lactamases (SBLs) inhibitors. Molecular modeling calculations vs GES-5 and crystallographic studies vs AmpC reasoned, respectively, the ortho derivative 2 and the meta derivative 3 binding affinity. The ability of our BAs to protect \u392-lactams from BLs hydrolysis was determined in biological assays conducted against clinical strains: Fractional inhibitory concentration index (FICI) tests confirmed their ability to be synergic with \u392-lactams thus restoring susceptibility to meropenem. Considering the obtained results and the lack of cytotoxicity, our derivatives represent validated probe for the design of SBLs inhibitors

    Virtual screening identifies broad-spectrum \u3b2-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemases

    Get PDF
    Bacteria are known to evade \u3b2-lactam antibiotic action by producing \u3b2-lactamases (BLs), including carbapenemases, which are able to hydrolyze nearly all available \u3b2-lactams. The production of BLs represents one of the best known and most targeted mechanisms of resistance in bacteria. We have performed the parallel screening of commercially available compounds against a panel of clinically relevant BLs: class A CTX-M-15 and KPC-2, subclass B1 NDM-1 and VIM-2 MBLs, and the class C P. aeruginosa AmpC. The results show that all BLs prefer scaffolds having electron pair donors: KPC-2 is preferentially inhibited by sulfonamide and tetrazole-based derivatives, NDM-1 by compounds bearing a thiol, a thiosemicarbazide or thiosemicarbazone moiety, while VIM-2 by triazole-containing molecules. Few broad-spectrum BLs inhibitors were identified; among these, compound 40 potentiates imipenem activity against an NDM-1-producing E. coli clinical strain. The binary complexes of the two most promising compounds binding NDM-1 and VIM-2 were obtained at high resolution, providing strong insights to improve molecular docking simulations, especially regarding the interaction of MBLs with inhibitors

    Discovery of new colonies by Sentinel2 reveals good and bad news for emperor

    Get PDF
    The distribution of emperor penguins is circumpolar, with 54 colony locations currently reported of which 50 are currently extant as of 2019. Here we report on eight newly discovered colonies and confirm the rediscovery of three breeding sites, only previously reported in the era before Very High Resolution satellite imagery was available, making a total of 61 breeding locations. This represents an increase of ~20% in the number of breeding sites, but, as most of the colonies appear to be small, they may only increase the total population by around 5–10%. The discoveries have been facilitated by the use of Sentinel2 satellite imagery, which has a higher resolution and more efficient search mechanism than the Landsat data previously used to search for colonies. The small size of these new colonies indicates that considerations of reproductive output in relation to metabolic rate during huddling is likely to be of interest. Some of the colonies exist in offshore habitats, something not previously reported for emperor penguins. Comparison with recent modelling results show that the geographic locations of all the newly found colonies are in areas likely to be highly vulnerable under business‐as‐usual greenhouse gas emissions scenarios, suggesting that population decreases for the species will be greater than previously thought

    CagI Is an Essential Component of the Helicobacter pylori Cag Type IV Secretion System and Forms a Complex with CagL

    Get PDF
    Helicobacter pylori, the causative agent of type B gastritis, peptic ulcers, gastric adenocarcinoma and MALT lymphoma, uses the Cag type IV secretion system to induce a strong proinflammatory response in the gastric mucosa and to inject its effector protein CagA into gastric cells. CagA translocation results in altered host cell gene expression profiles and cytoskeletal rearrangements, and it is considered as a major bacterial virulence trait. Recently, it has been shown that binding of the type IV secretion apparatus to integrin receptors on target cells is a crucial step in the translocation process. Several bacterial proteins, including the Cag-specific components CagL and CagI, have been involved in this interaction. Here, we have examined the localization and interactions of CagI in the bacterial cell. Since the cagI gene overlaps and is co-transcribed with the cagL gene, the role of CagI for type IV secretion system function has been difficult to assess, and conflicting results have been reported regarding its involvement in the proinflammatory response. Using a marker-free gene deletion approach and genetic complementation, we show now that CagI is an essential component of the Cag type IV secretion apparatus for both CagA translocation and interleukin-8 induction. CagI is distributed over soluble and membrane-associated pools and seems to be partly surface-exposed. Deletion of several genes encoding essential Cag components has an impact on protein levels of CagI and CagL, suggesting that both proteins require partial assembly of the secretion apparatus. Finally, we show by co-immunoprecipitation that CagI and CagL interact with each other. Taken together, our results indicate that CagI and CagL form a functional complex which is formed at a late stage of secretion apparatus assembly

    A Liposome-Based Mycobacterial Vaccine Induces Potent Adult and Neonatal Multifunctional T Cells through the Exquisite Targeting of Dendritic Cells

    Get PDF
    BACKGROUND: In the search for more potent and safer tuberculosis vaccines, CAF01 was identified as a remarkable formulation. Based on cationic liposomes and including a synthetic mycobacterial glycolipid as TLR-independent immunomodulator, it induces strong and protective T helper-1 and T helper-17 adult murine responses to Ag85B-ESAT-6, a major mycobacterial fusion protein. Here, we assessed whether these properties extend to early life and how CAF01 mediates its adjuvant properties in vivo. METHODS/FINDINGS: Following adult or neonatal murine immunization, Ag85B-ESAT-6/CAF01 similarly reduced the post-challenge bacterial growth of M. bovis BCG, whereas no protection was observed using Alum as control. This protection was mediated by the induction of similarly strong Th1 and Th17 responses in both age groups. Multifunctional Th1 cells were already elicited after a single vaccine dose and persisted at high levels for at least 6 months even after neonatal priming. Unexpectedly, this potent adjuvanticity was not mediated by a massive targeting/activation of dendritic cells: in contrast, very few DCs in the draining lymph nodes were bearing the labeled antigen/adjuvant. The increased expression of the CD40 and CD86 activation markers was restricted to the minute portion of adjuvant-bearing DCs. However, vaccine-associated activated DCs were recovered several days after immunization. CONCLUSION: The potent adult and neonatal adjuvanticity of CAF01 is associated in vivo with an exquisite but prolonged DC uptake and activation, fulfilling the preclinical requirements for novel tuberculosis vaccines to be used in early life

    Characterization of Maltoheptaose and Complex Glycoprotein Glycan Structure by LC/MS

    No full text
    Characterization of Complex Glycoprotein Glycan Structures by LC/MS Sebastien Cendron, Emily McLaughlin, Christopher N. LaFratta Chemistry Department, Bard College, Annadale-on-Hudson, NY. Hui Zhou, John Froehlich, Children’s Hospital Boston, Boston, MA. The relatively new field of glycomics studies the complete set of glycan structures belonging to a set of proteins, a cell, or an organism. In this work, we seek to isolate and characterize the glycan from ribonuclease B using liquid chromatography and tandem mass spectrometry. The overall procedure involves a reductive alkylation and enzymatic release of the glycans, followed by permethylation of the glycan before LC-MS analysis. A control sample maltoheptose were used to verify the reaction and analysis conditions. Chromatography of methylated maltoheptaose yielded insight into the relative quantities of fully and partially methylated products, a side reaction between the reagents used in permethylation, the presence of α and ß anomers, and stereochemical features of the maltoheptaose-C18 affinity. The cyclic nature of the standard’s reducing end sugar was further confirmed by tandem mass spectrometry. Isolation of glycan from ribonuclease B was then carried out with a reduction and alkylation of the protein, spin filtration, enzymatic deglycosylation, and liquid phase permethylation. Analysis of mass spectral data on the ribonuclease B glycan is only partially complete

    Structure of the uncomplexed Neisseria meningitidis factor H-binding protein fHbp (rLP2086)

    No full text
    fHbp, a highly immunogenic outer membrane protein of Neisseria meningitidis, is responsible for binding to human factor H, a multi-domain protein which is the central regulator of the alternative complement pathway. Here, the crystal structure of mature fHbp determined at 2 \uc5 resolution is presented and is compared with the structure of the same protein in complex with factor H domains 6 and 7 recently solved using X-ray techniques. While the overall protein fold is well conserved, modifications are observed mainly in the loop regions involved in the interaction, reflecting a specific adaptation of fHbp in complexing factor H with high affinity. Such a comparison has to date been impaired by the fact that fHbp models determined by NMR show remarkable differences over the entire structure
    corecore